BioCentury | Oct 10, 2018
Company News

Management tracks: Hamburg joins Alnylam board

...a managing partner at Cardinal Partners and was Alnylam's chairman in 2002-15. Drug delivery company Tris Pharma Inc....
BioCentury | Sep 1, 2017
Company News

Management tracks: BioDelivery, Almirall, Nabriva

...disease company Humanigen Inc. (OTCQB:KBIO) named Greg Jester CFO. He was VP of finance at Tris Pharma Inc....
BioCentury | Aug 11, 2017
Clinical News

FDA issues CRL to NDA for Vernalis' CCP-08

...CCP-07 are undisclosed, existing cough and cold medications reformulated using OralXR+ extended-release formulation technology from Tris Pharma Inc....
...Tris Pharma Inc. , Monmouth Junction, N.J. Vernalis plc (LSE:VER), Winnersh, U.K. Product: CCP-08 Business: Pulmonary Alex Himes CCP-07 CCP-08 Tris Pharma Inc. Vernalis...
BioCentury | Aug 7, 2017
Company News

Vernalis gets another CRL in cough and cold pipeline

...CCP-07 are undisclosed, existing cough and cold medications reformulated using OralXR+ extended-release formulation technology from Tris Pharma Inc....
...polistirex in 2015 (see BioCentury Extra, Feb. 10, 2012 & May 1, 2015) . Alex Himes CCP-07 CCP-08 Tuzistra XR Tris Pharma Inc. Vernalis...
BioCentury | Jul 8, 2017
Finance

A clinical quarter

...data 3Q17 Trevena Inc. (NASDAQ:TRVN) Olinvo oliceridine Moderate to severe acute pain Submit NDA 4Q17 Tris Pharma Inc....
BioCentury | Jul 7, 2017
Finance

Onward and upward

...letter for Cimzia certolizumab pegol to treat polyarticular juvenile idiopathic arthritis Vernalis plc (LSE:VER) / Tris Pharma Inc....
BioCentury | Apr 26, 2017
Clinical News

CCP-07 regulatory update

...Tris Pharma Inc. , Monmouth Junction, N.J. Vernalis plc (LSE:VER), Winnersh, U.K. Product: CCP-07 Business: Pulmonary Alicia Parker CCP-07 Tris Pharma Inc. Vernalis...
BioCentury | Apr 21, 2017
Company News

Vernalis gets CRL for CCP-07

...is an undisclosed existing cough and cold product that uses OralXR+ extended-release formulation technology from Tris Pharma Inc....
...rights to commercialize up to 6 reformulated prescription cough and cold products using Tris’ OralXR+. Alicia Parker CCP-07 Tris Pharma Inc. Vernalis...
BioCentury | Mar 13, 2017
Company News

Management tracks

...Head of Discovery and President and CEO for North America Andrew Heaton. Drug delivery company Tris Pharma Inc....
BioCentury | Dec 30, 2016
Clinical News

CCP-08 regulatory update

...Tris Pharma Inc. , Monmouth Junction, N.J. Vernalis plc (LSE:VER), Winnersh, U.K. Product: CCP-08 Business: Pulmonary Julian Zhu CCP-08 Tris Pharma Inc. Vernalis...
Items per page:
1 - 10 of 43
BioCentury | Oct 10, 2018
Company News

Management tracks: Hamburg joins Alnylam board

...a managing partner at Cardinal Partners and was Alnylam's chairman in 2002-15. Drug delivery company Tris Pharma Inc....
BioCentury | Sep 1, 2017
Company News

Management tracks: BioDelivery, Almirall, Nabriva

...disease company Humanigen Inc. (OTCQB:KBIO) named Greg Jester CFO. He was VP of finance at Tris Pharma Inc....
BioCentury | Aug 11, 2017
Clinical News

FDA issues CRL to NDA for Vernalis' CCP-08

...CCP-07 are undisclosed, existing cough and cold medications reformulated using OralXR+ extended-release formulation technology from Tris Pharma Inc....
...Tris Pharma Inc. , Monmouth Junction, N.J. Vernalis plc (LSE:VER), Winnersh, U.K. Product: CCP-08 Business: Pulmonary Alex Himes CCP-07 CCP-08 Tris Pharma Inc. Vernalis...
BioCentury | Aug 7, 2017
Company News

Vernalis gets another CRL in cough and cold pipeline

...CCP-07 are undisclosed, existing cough and cold medications reformulated using OralXR+ extended-release formulation technology from Tris Pharma Inc....
...polistirex in 2015 (see BioCentury Extra, Feb. 10, 2012 & May 1, 2015) . Alex Himes CCP-07 CCP-08 Tuzistra XR Tris Pharma Inc. Vernalis...
BioCentury | Jul 8, 2017
Finance

A clinical quarter

...data 3Q17 Trevena Inc. (NASDAQ:TRVN) Olinvo oliceridine Moderate to severe acute pain Submit NDA 4Q17 Tris Pharma Inc....
BioCentury | Jul 7, 2017
Finance

Onward and upward

...letter for Cimzia certolizumab pegol to treat polyarticular juvenile idiopathic arthritis Vernalis plc (LSE:VER) / Tris Pharma Inc....
BioCentury | Apr 26, 2017
Clinical News

CCP-07 regulatory update

...Tris Pharma Inc. , Monmouth Junction, N.J. Vernalis plc (LSE:VER), Winnersh, U.K. Product: CCP-07 Business: Pulmonary Alicia Parker CCP-07 Tris Pharma Inc. Vernalis...
BioCentury | Apr 21, 2017
Company News

Vernalis gets CRL for CCP-07

...is an undisclosed existing cough and cold product that uses OralXR+ extended-release formulation technology from Tris Pharma Inc....
...rights to commercialize up to 6 reformulated prescription cough and cold products using Tris’ OralXR+. Alicia Parker CCP-07 Tris Pharma Inc. Vernalis...
BioCentury | Mar 13, 2017
Company News

Management tracks

...Head of Discovery and President and CEO for North America Andrew Heaton. Drug delivery company Tris Pharma Inc....
BioCentury | Dec 30, 2016
Clinical News

CCP-08 regulatory update

...Tris Pharma Inc. , Monmouth Junction, N.J. Vernalis plc (LSE:VER), Winnersh, U.K. Product: CCP-08 Business: Pulmonary Julian Zhu CCP-08 Tris Pharma Inc. Vernalis...
Items per page:
1 - 10 of 43